Study guide

10.4 Fluid, Electrolyte & Acid-Base Disorders

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

10.4 Fluid, Electrolyte & Acid-Base Disorders

Key Takeaways Explain This Topic AI

Hyponatremia evaluation requires checking serum osmolality; hypotonic hyponatremia is categorized by volume status: hypovolemic (Uristick Na <20 mEq/L vs >20 mEq/L), euvolemic (SIADH: urine osmolality >100 mOsm/kg, urine Na >40 mEq/L), and hypervolemic (heart failure, cirrhosis, nephrotic syndrome).

Rapid correction of chronic hyponatremia (>4-8 mEq/L in 24 hours) risks Osmotic Demyelination Syndrome (central pontine myelinolysis), whereas rapid correction of hypernatremia risks cerebral edema.

Hyperkalemia (K+ >5.2 mEq/L) management involves membrane stabilization with IV calcium gluconate if ECG changes are present (peaked T waves, PR prolongation, widened QRS), followed by intracellular shunting (insulin + glucose, albuterol, sodium bicarbonate) and elimination (furosemide, patiromer, hemodialysis).

Primary Metabolic Acidosis requires calculating the Anion Gap [Na+ - (Cl- + HCO3-)]; normal gap is 8-12 mEq/L, and high anion gap (>12 mEq/L) causes are remembered by MUDPILES (Methanol, Uremia, DKA, Propylene glycol, INH/Iron, Lactic acidosis, Ethylene glycol, Salicylates).

Respiratory compensation for metabolic acidosis is predicted by Winters' formula: Expected pCO2 = (1.5 x [HCO3-]) + 8 +/- 2; if actual pCO2 > expected pCO2, a concurrent respiratory acidosis is present.

Last updated: July 2026

Diagnostic Approach to Hyponatremia & Hypernatremia

Sodium disorders represent imbalances of water homeostasis rather than total body sodium content. On USMLE Step 2 CK, evaluating hyponatremia follows a systematic 3-step diagnostic algorithm. [ Measured Serum Na <135 mEq/L ]

  • |
  • [ Step 1: Check Serum Osmolality ]
  • |
  • +------------------------------+------------------------------+
  • | | |
  • [ High (>295) ] [ Normal (280-295) ] [ Low (<280) ]
  • Hypertonic Hyponatremia Pseudohyponatremia Hypotonic Hyponatremia
  • (Hyperglycemia, Mannitol) (Hypertriglyceridemia) |
  • [ Step 2: Assess Volume ]
  • |
  • +--------------------------------+----------------------------+
  • | | |
  • [ Hypovolemic ] [ Euvolemic ] [ Hypervolemic ]
  • Urine Na <20: GI Loss / Dehydration SIADH (Urine Osm >100) Heart Failure
  • Urine Na >20: Diuretics / Addison Psychogenic Polydipsia Cirrhosis / Nephrotic
  • Clinical Management of Hyponatremia & Correction Limits

Osmotic Demyelination Syndrome (ODS / Central Pontine Myelinolysis) : Occurs when chronic hyponatremia is corrected too rapidly ( >8 mEq/L in 24 hours ). Rapid extracellular hypertonicity draws water out of pontine myelin sheath cells, causing dysarthria, dysphagia, paraparesis, or locked-in syndrome.

Severe Symptomatic Hyponatremia : Patients presenting with seizures, confusion, or coma require immediate hypertonic 3% saline bolus (100–150 mL) to raise serum sodium by 4–6 mEq/L over 1–2 hours, symptomatically reversing acute cerebral edema.

SIADH Treatment : First-line therapy for asymptomatic euvolemic hyponatremia is fluid restriction (<800–1000 mL/day) . Oral salt tablets, loop diuretics, or vasopressin receptor antagonists (vaptans) are added if fluid restriction fails.

Hypernatremia

Hypernatremia (serum Na+ >145 mEq/L) reflects a deficit of free water relative to solute. Causes include Diabetes Insipidus (DI) :

Central DI : Deficiency of ADH release from posterior pituitary (head trauma, pituitary lesions). Responds to exogenous desmopressin (dDAVP) with a >50% increase in urine osmolality.

Nephrogenic DI : Renal resistance to ADH (lithium toxicity, hypercalcemia, hypokalemia). Does not respond to desmopressin; managed with thiazides and amiloride.

Correction Rate Limit : Overly rapid correction of hypernatremia with hypotonic fluids risks cerebral edema (water shifts into brain cells). Correct at a maximum rate of <10 mEq/L/day .

  • Potassium Disorders
  • Hyperkalemia Management Sequence

Hyperkalemia (serum K+ >5.2 mEq/L) causes cardiac membrane instability leading to fatal arrhythmias (sine waves, ventricular fibrillation). Treatment follows a precise 3-phase emergency protocol:

Membrane Stabilization (Immediate) : Intravenous Calcium Gluconate (or Calcium Chloride). Restores cardiac membrane threshold potential without altering serum potassium level. Mandatory if ECG shows peaked T waves, PR prolongation, or QRS widening.

Intracellular Potassium Shunting (Rapid onset, temporary) :

Insulin (10 units regular IV) plus 50% Dextrose (50 mL) : Drives K+ into cells via Na+/K+ ATPase stimulation.

Inhaled Albuterol (10-20 mg) : Beta-2 adrenergic agonist driving intracellular K+ shift.

Sodium Bicarbonate IV : Used primarily if severe metabolic acidosis is present.

Potassium Elimination from Body (Definitive) :

Loop Diuretics (Furosemide) : Increases renal K+ excretion in patients with preserved renal function.

Cation Exchange Resins / Potassium Binders : Patiromer or Sodium Zirconium Cyclosilicate (SZC).

Hemodialysis : Definitive therapy in severe AKI/ESRD.

Hypokalemia & Hypomagnesemia

Hypokalemia (serum K+ <3.5 mEq/L) causes muscle weakness, cramps, constipation, and ECG abnormalities ( flattened T waves, ST depression, U waves ). On Step 2 CK, if hypokalemia is refractory to oral/IV potassium replacement, check and correct serum magnesium . Hypomagnesemia disinhibits the Outer Medullary Potassium (ROMK) channels in renal collecting ducts, causing continuous urinary potassium wasting.

  • Acid-Base Interpretation & Renal Tubular Acidosis
  • Systematic 4-Step Acid-Base Workflow

Assess pH : Acidemia (<7.35) vs. Alkalemia (>7.45).

Identify Primary Process : Compare pH change with pCO2 and serum HCO3⁻.

Calculate Anion Gap (if Metabolic Acidosis present): Anion Gap = [ Na + ] − ( [ Cl − ] + [ HCO 3 − ] ) ( Normal: 8 − 12 mEq/L ) \text{Anion Gap} = [\text{Na}^+] - ([\text{Cl}^-] + [\text{HCO}_3^-]) \quad (\text{Normal: } 8 - 12\text{ mEq/L}) Anion Gap = [ Na + ] − ([ Cl − ] + [ HCO 3 − ​ ]) ( Normal: 8 − 12 mEq/L )

High Anion Gap Metabolic Acidosis (HAGMA) (>12 mEq/L): Mnemonic MUDPILES (Methanol, Uremia, Diabetic Ketoacidosis, Propylene glycol, Isoniazid/Iron, Lactic acidosis, Ethylene glycol, Salicylates).

Normal Anion Gap (Hyperchloremic) Metabolic Acidosis (8-12 mEq/L): Mnemonic HARDASS (Hyperalimentation, Acetazolamide, Renal Tubular Acidosis, Diarrhea, Addison disease, Spironolactone, Saline infusion).

Evaluate Compensation :

Winters' Formula for Metabolic Acidosis : Predicts expected pCO2: Expected p CO 2 = ( 1.5 × [ HCO 3 − ] ) + 8 ± 2 \text{Expected } p\text{CO}_2 = (1.5 \times [\text{HCO}_3^-]) + 8 \pm 2 Expected p CO 2 ​ = ( 1.5 × [ HCO 3 − ​ ]) + 8 ± 2

If measured pCO2 > expected pCO2 -> Concurrent Respiratory Acidosis .

If measured pCO2 < expected pCO2 -> Concurrent Respiratory Alkalosis .

Renal Tubular Acidosis (RTA) Summary

RTA Type Pathophysiologic Defect Serum K+ Level Urine pH Key Clinical Associations / Diagnostic Test

Type 1 (Distal RTA) Inability of distal tubule alpha-intercalated cells to secrete H⁺ Hypokalemia >5.5 (Inability to acidify urine) Associated with autoimmune diseases (Sjögren); leads to nephrolithiasis / nephrocalcinosis (calcium phosphate stones)

Type 2 (Proximal RTA) Impaired proximal tubular reabsorption of HCO3⁻ Hypokalemia <5.5 (after HCO3⁻ filtered load drops below threshold) Associated with Fanconi syndrome (multiple myeloma, Wilson disease, tenofovir toxicity); causes osteomalacia

Type 4 (Hypoaldosteronism) Aldosterone deficiency or distal tubular resistance Hyperkalemia <5.5 Most common RTA; seen in diabetic nephropathy , elderly with interstitial nephritis, ACEi/ARB use